logo

HCWB

HCW Biologics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

HCWB Profile

Hcw Biologics Inc.

A clinical-stage biopharmaceutical company that develops immunotherapes for the treatment of age-related diseases

Pharmaceutical
04/02/2018
07/20/2021
NASDAQ Stock Exchange
36
12-31
Common stock
2929 N Commerce Parkway, Miramar, Florida 33025
--
HCW Biologics Inc., was incorporated in Delaware on April 2, 2018. The company is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to extend the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes that age-related chronic low-grade inflammation, or "inflammation," is an important factor in several diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative disease and autoimmune disease.